Assesment Of Symptom Limited Stair Climbing Test Efficacy İn Patients With Chronic Heart Failure

  • Yazar/lar ALKAN, Büşra
    ÖZALEVLİ, Sevgi
    GÜLLÜ, Nezire
  • Yayın Türü Konferans Bildirisi
  • Yayın Tarihi 2018
  • Yayıncı Euroopean Society of Cardiology
  • Tek Biçim Adres https://hdl.handle.net/20.500.12498/856

Introduction: To assess the efficacy of symptom-limited stair climbing test (SLSCT), in determining exercise capacities of patients with chronic heart failure (CHF) by comparing cardiopulmonary exercise test (CPET) and 6-minute walk test (6 MWT) and to interpret the results according to clinical characteristics of patients. Methods: The study included 31 patients aged 50-75 years with stage II-III according to the NYHA (Newyork Heart Association) classification, diagnosed with CHF, with a left ventricular ejection fraction (LVEF) of 45% or less. Demographic and clinical characteristics of the patients were questioned. Exercise capacity was assessed by SLSCT, 6 MWT, CPET. Patients dyspnea and effort perception were assessed by Modified Borg Scale (MBS), pulmonary functions by spirometric measurements, health-related quality of life (HRQOL) by Chronic Heart Failure Questionnaire (CHFQ). Results: It was determined that the test with the highest VO2 max value among the tests was SLSCT. A significant difference was noted between the other tests (p <0.05). In heart rate changes before and after the tests, SLSCT was found to increase heart rate more than 6MWT and less than CPET. A significant correlation was found between the predicted VO2max values of CPET and SLSCT (r = 0.52, p = 0.003). It was also found that SLSCT was more related to clinical characteristics of patients. Conclusion: SLSCT is effective in evaluating exercise capacity and easy to use in CHF patients. Compared with the 6MWT, it gives better results in determining the clinical characteristics and hemodynamic responses of the patients. It is an alternative to assessing exercise capacity in the absence of CPET.

Erişime Açık
Görüntülenme
2
22.03.2024 tarihinden bu yana
İndirme
1
22.03.2024 tarihinden bu yana
Son Erişim Tarihi
18 Mayıs 2024 13:34
Google Kontrol
Tıklayınız
Tam Metin
Tam Metin İndirmek için tıklayın Ön izleme
Detaylı Görünüm
Eser Adı
(dc.title)
Assesment Of Symptom Limited Stair Climbing Test Efficacy İn Patients With Chronic Heart Failure
Yayın Türü
(dc.type)
Konferans Bildirisi
Yazar/lar
(dc.contributor.author)
ALKAN, Büşra
Yazar/lar
(dc.contributor.author)
ÖZALEVLİ, Sevgi
Yazar/lar
(dc.contributor.author)
GÜLLÜ, Nezire
Atıf Dizini
(dc.source.database)
Diğer
Yayıncı
(dc.publisher)
Euroopean Society of Cardiology
Yayın Tarihi
(dc.date.issued)
2018
Kayıt Giriş Tarihi
(dc.date.accessioned)
2019-07-09T12:27:28Z
Açık Erişim tarihi
(dc.date.available)
2019-07-09T12:27:28Z
Özet
(dc.description.abstract)
Introduction: To assess the efficacy of symptom-limited stair climbing test (SLSCT), in determining exercise capacities of patients with chronic heart failure (CHF) by comparing cardiopulmonary exercise test (CPET) and 6-minute walk test (6 MWT) and to interpret the results according to clinical characteristics of patients. Methods: The study included 31 patients aged 50-75 years with stage II-III according to the NYHA (Newyork Heart Association) classification, diagnosed with CHF, with a left ventricular ejection fraction (LVEF) of 45% or less. Demographic and clinical characteristics of the patients were questioned. Exercise capacity was assessed by SLSCT, 6 MWT, CPET. Patients dyspnea and effort perception were assessed by Modified Borg Scale (MBS), pulmonary functions by spirometric measurements, health-related quality of life (HRQOL) by Chronic Heart Failure Questionnaire (CHFQ). Results: It was determined that the test with the highest VO2 max value among the tests was SLSCT. A significant difference was noted between the other tests (p <0.05). In heart rate changes before and after the tests, SLSCT was found to increase heart rate more than 6MWT and less than CPET. A significant correlation was found between the predicted VO2max values of CPET and SLSCT (r = 0.52, p = 0.003). It was also found that SLSCT was more related to clinical characteristics of patients. Conclusion: SLSCT is effective in evaluating exercise capacity and easy to use in CHF patients. Compared with the 6MWT, it gives better results in determining the clinical characteristics and hemodynamic responses of the patients. It is an alternative to assessing exercise capacity in the absence of CPET.
Yayın Dili
(dc.language.iso)
en
Tek Biçim Adres
(dc.identifier.uri)
https://hdl.handle.net/20.500.12498/856
Analizler
Yayın Görüntülenme
Yayın Görüntülenme
Erişilen ülkeler
Erişilen şehirler
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve cerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms